Login / Signup

Investigational drugs for HIV: trends, opportunities and key players.

Ronald J OvermarsZoë KrullaarsThibault Mesplede
Published in: Expert opinion on investigational drugs (2023)
While the field focuses on extending dosing intervals, we identify drug tissue penetration as an understudied opportunity to improve HIV care. We repeat that self-administration remains an essential milestone to reach the full potential of long-acting drugs. Treatments and prevention strategies based on broadly neutralizing antibodies require a deeper understanding of their antiretroviral properties.
Keyphrases